JPY 562.0
(4.07%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenue | 2.35 Billion | 989.24 Million | 674.14 Million | 506.63 Million |
Cost of Revenue | 1.42 Billion | 436.46 Million | 339.54 Million | 170.31 Million |
Gross Profit | 928.24 Million | 552.77 Million | 334.59 Million | 336.32 Million |
Operating Expenses | 6.42 Billion | 11.57 Billion | 4.39 Billion | 2.96 Billion |
Selling, General and Administrative Expenses | 1.59 Billion | 1.64 Billion | 727.81 Million | 518.46 Million |
Research and Development Expenses | 3.83 Billion | 9.23 Billion | 3.25 Billion | 2.15 Billion |
Other Expenses | 997.19 Million | -241.99 Million | -4.79 Million | 8.96 Million |
Cost and Expenses | 7.85 Billion | 12.01 Billion | 4.73 Billion | 3.13 Billion |
Operating Income | -5.5 Billion | -11.02 Billion | -4.05 Billion | -2.62 Billion |
Interest Expense | 688.78 Million | 196.15 Million | 24.94 Million | 1.94 Million |
Income Tax Expense | 18.67 Million | 19.6 Million | 15.71 Million | 3.94 Million |
Earnings before Tax | -2.34 Billion | -11.37 Billion | -4.04 Billion | -2.61 Billion |
Net Income | -2.36 Billion | -11.39 Billion | -4.05 Billion | -2.61 Billion |
Earnings Per Share Basic | -29.05 | -211.47 | -54.99 | -48.51 |
Earnings Per Share Diluted | -29.05 | -211.47 | -54.99 | -32.52 |
Weighted Average Shares Outstanding | 81.45 Million | 53.9 Million | 73.83 Million | 53.9 Million |
Weighted Average Shares Outstanding (Diluted) | 81.45 Million | 53.9 Million | 73.83 Million | 80.42 Million |
Gross Margin | 0.39 | 0.56 | 0.50 | 0.66 |
EBIT Margin | -0.67 | -11.23 | -5.86 | -5.03 |
Profit Margin | -1.00 | -11.52 | -6.02 | -5.16 |
EBITDA | -1.57 Billion | -11.11 Billion | -3.95 Billion | -2.53 Billion |
Earnings Before Tax Margin | -2.33 | -11.14 | -6.02 | -5.18 |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 635.52 Million | 2.35 Billion | 530.99 Million | 496.02 Million | 514.59 Million | 815.44 Million |
Cost of Revenue | 528.15 Million | 1.42 Billion | 407.41 Million | 377.4 Million | 400.39 Million | 243.59 Million |
Gross Profit | 107.37 Million | 928.24 Million | 123.57 Million | 118.61 Million | 114.2 Million | 571.85 Million |
Operating Expenses | 2.4 Billion | 6.42 Billion | 1.87 Billion | 1.82 Billion | 1.04 Billion | 1.68 Billion |
Selling, General and Administrative Expenses | 2.4 Billion | - | 1.95 Billion | 1.82 Billion | 1.04 Billion | 1.68 Billion |
Research and Development Expenses | - | - | 3.83 Billion | 1.06 Billion | - | - |
Other Expenses | - | -567.13 Million | -68.76 Million | -24.3 Million | -356 Thousand | -473.7 Million |
Cost and Expenses | 2.93 Billion | 7.85 Billion | 2.28 Billion | 2.2 Billion | 1.44 Billion | 1.92 Billion |
Operating Income | -2.29 Billion | -5.5 Billion | -1.75 Billion | -1.7 Billion | -931.17 Million | -1.1 Billion |
Interest Expense | - | 367.99 Million | 137.96 Million | 106.99 Million | 65.68 Million | 57.35 Million |
Income Tax Expense | 2.16 Million | 18.67 Million | 21.69 Million | -1.23 Million | -1.13 Million | -656 Thousand |
Earnings before Tax | -1.57 Billion | -2.34 Billion | -1.5 Billion | -2.37 Billion | 2.91 Billion | -1.37 Billion |
Net Income | -1.57 Billion | -2.36 Billion | -1.52 Billion | -2.37 Billion | 2.91 Billion | -1.37 Billion |
Earnings Per Share Basic | -16.95 | - | -18.38 | -28.86 | 35.51 | -17.55 |
Earnings Per Share Diluted | -16.95 | - | -18.38 | -28.85 | 31.36 | -17.55 |
Weighted Average Shares Outstanding | 93.14 Million | 81.45 Million | 83.19 Million | 82.28 Million | 92.82 Million | 78.32 Million |
Weighted Average Shares Outstanding (Diluted) | 93.14 Million | 81.45 Million | 83.19 Million | 82.32 Million | 92.86 Million | 78.32 Million |
Gross Margin | 0.17 | 0.39 | 0.23 | 0.24 | 0.22 | 0.70 |
EBIT Margin | -3.58 | - | -2.58 | -4.49 | 5.79 | -1.62 |
Profit Margin | -2.48 | -1.00 | -2.88 | -4.79 | 5.66 | -1.69 |
EBITDA | -2.27 Billion | - | -1.36 Billion | -2.22 Billion | 2.97 Billion | -1.31 Billion |
Earnings Before Tax Margin | -3.61 | -2.33 | -3.30 | -3.44 | -1.81 | -1.36 |
3468
EKCS
CDMGF
7BP
FRAS3
DOW